Search Results - "Steenwyk, R C"
-
1
In vitro evidence for the formation of reactive intermediates of resveratrol in human liver microsomes
Published in Xenobiotica (01-01-2010)“…Resveratrol (3,4′,5-trihydroxystilbene) is a naturally occurring polyphenolic compound found in a variety of foods and over-the-counter health products. It has…”
Get full text
Journal Article -
2
Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine
Published in Psychopharmacologia (01-09-1991)“…The pharmacokinetic and pharmacodynamic effects of concomitant administration of alprazolam and fluoxetine were studied in this double-blind parallel study in…”
Get full text
Journal Article -
3
Biotransformation of tirilazad in human: 1. Cytochrome P450 3A-mediated hydroxylation of tirilazad mesylate in human liver microsomes
Published in The Journal of pharmacology and experimental therapeutics (01-05-1996)“…Tirilazad mesylate (Freedox), a potent inhibitor of membrane lipid peroxidation in vitro, is under clinical development for the treatment of subarachnoid…”
Get more information
Journal Article -
4
Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: II. Multiple-dose administration
Published in Journal of clinical pharmacology (01-02-1993)“…The multiple dose tolerability and pharmacokinetics of tirilazad mesylate, a 21-aminosteroid free radical scavenger, were assessed in 50 healthy male…”
Get more information
Journal Article -
5
Replacing 14C with stable isotopes in drug metabolism studies
Published in Drug metabolism and disposition (01-07-1996)“…After administration of a mixed dose of both radioisotope and stable-isotope-labeled tirilazad, we carried out a parallel set of HPLC analyses for drug…”
Get more information
Journal Article -
6
A pharmacokinetic evaluation of the combined administration of triazolam and fluoxetine
Published in Pharmacotherapy (01-01-1992)“…The influence of fluoxetine on triazolam pharmacokinetics was studied because of changes in diazepam pharmacokinetics reportedly produced by fluoxetine…”
Get more information
Journal Article -
7
Inhibition of in vitro lipid peroxidation by 21-aminosteroids. Evidence for differential mechanisms
Published in Biochemical pharmacology (01-09-1993)“…In a previous report (Ryan and Petry, Arch Biochem Biophys 300: 699-704, 1993), the effects of two 21-aminosteroids (U-74500A and U-74006F) on the oxidation…”
Get more information
Journal Article -
8
Mechanism-Based Inactivation of Cytochrome P450 2D6 by 1-[(2-Ethyl-4-methyl-1H-imidazol-5-yl)methyl]- 4-[4-(trifluoromethyl)-2-pyridinyl]piperazine: Kinetic Characterization and Evidence for Apoprotein Adduction
Published in Chemical research in toxicology (01-02-2004)“…The kinetics for inactivation of cytochrome P450 2D6 by (1-[(2-ethyl-4-methyl-1H-imidazol-5-yl)methyl]-4-[4-(trifluoromethyl)-2-pyridinyl]piperazine (EMTPP)…”
Get full text
Journal Article -
9
In vitro metabolism of tirilazad mesylate in male and female rats. Contribution of cytochrome P4502C11 and delta 4-5 alpha-reductase
Published in Drug metabolism and disposition (01-03-1995)“…Tirilazad mesylate, a potent inhibitor of membrane lipid peroxidation in vitro, is under clinical development for the treatment of subarachnoid hemorrhage and…”
Get more information
Journal Article -
10
Identification of N-Acetylcysteine Conjugates of 1,2-Dibromo-3-chloropropane: Evidence for Cytochrome P450 and Glutathione Mediated Bioactivation Pathways
Published in Chemical research in toxicology (01-06-1995)“…The haloalkane 1,2-dibromo-3-chloropropane (DBCP) is a carcinogen, mutagen, nephrotoxin, and testicular toxin. The identification of N-acetylcysteine…”
Get full text
Journal Article -
11
Biotransformation of tirilazad in human: 3. tirilazad A-ring reduction by human liver microsomal 5alpha-reductase type 1 and type 2
Published in The Journal of pharmacology and experimental therapeutics (01-11-1998)“…Tirilazad mesylate (FREEDOX), a potent inhibitor of membrane lipid peroxidation in vitro, is under clinical development for the treatment of subarachnoid…”
Get more information
Journal Article